Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
9.55
-0.54 (-5.35%)
Jan 10, 2025, 11:40 AM EST - Market open
Emergent BioSolutions Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for EBS stock have an average target of 14.33, with a low estimate of 12 and a high estimate of 16. The average target predicts an increase of 50.05% from the current stock price of 9.55.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for EBS stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +57.07% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +57.07% | Dec 30, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $8 → $12 | Strong Buy | Maintains | $8 → $12 | +25.65% | Nov 7, 2024 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +67.54% | Sep 13, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | -16.23% | Aug 16, 2024 |
Financial Forecast
Revenue This Year
1.12B
from 1.05B
Increased by 6.64%
Revenue Next Year
1.21B
from 1.12B
Increased by 7.95%
EPS This Year
-1.01
from -14.85
EPS Next Year
3.02
from -1.01
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.2B | 1.3B | 1.1B | ||
| Avg | 1.1B | 1.2B | 1.1B | ||
| Low | 1.1B | 1.2B | 1.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.8% | 12.2% | -6.0% | ||
| Avg | 6.6% | 8.0% | -9.6% | ||
| Low | 3.5% | 4.7% | -12.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.05 | 3.14 | 2.29 |
| Avg | -1.01 | 3.02 | 2.20 |
| Low | -0.98 | 2.93 | 2.14 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | -24.2% |
| Avg | - | - | -27.1% |
| Low | - | - | -29.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.